Comparison of Abbott RealTime High Risk HPV and Hybrid Capture 2 for the detection of high-risk HPV DNA in a referral population setting
✍ Scribed by Simona Venturoli; Elisa Leo; Martina Nocera; Daniela Barbieri; Monica Cricca; Silvano Costa; Donatella Santini; Marialuisa Zerbini
- Book ID
- 116632223
- Publisher
- Elsevier Science
- Year
- 2012
- Tongue
- English
- Weight
- 178 KB
- Volume
- 53
- Category
- Article
- ISSN
- 1386-6532
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract A hybrid capture test that can be used to detect at least 13 high‐risk HPV types (referred to collectively as HPV‐HR) in cervical scrapes (Hybrid Capture 2 probe set B, HC2‐B) was evaluated. The HC2‐B test is accurate and highly reproducible and the results obtained show excellent agree
We assessed the detection of high-risk human papillomavirus DNA (HPV-DNA) in women examined by a second Pap smear due to atypical glandular cells (AGC) detected in their screening Pap smear. In 91 women included in the study, a second Pap smear was taken and HPV-DNA test was performed using Hybrid C
## Abstract The PapilloCheck® assay was compared with the Digene HC2 HPV DNA assay for the detection of 13 high‐risk human papillomaviruses (HPV) in 240 samples, including 181 cervical scrapes and 59 anal scrapes. Overall, 75 (30.5%) samples were positive by the Digene HC2 HPV DNA assay: 34 (18.8%)